Repligen | RGEN - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Agilent USD 29M 4M 2026-06
Align Technology USD 6.93M 9.11M 2026-03
Bio Techne USD 3.6M 1.19M 2026-06
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Bristol-Myers Squibb USD 407M 4M 2026-06
Bruker USD 17.8M 9.7M 2026-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Danaher USD 135M 28M 2026-09
Dentsply International USD 22M 2M 2026-06
General Electric Aerospace USD 231M 265M 2026-09
Henry Schein USD 43M 4M 2026-06
Illumina USD 24M 2M 2026-03
IQVIA Holdings USD 197M 5M 2026-06
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pfizer USD 667M 4M 2026-06
Repligen USD 5.66M 85K 2026-06
Revvity USD 22.99M 1.73M 2026-06
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 417M 63M 2026-09
Waters USD 55M 13M 2026-06
West Pharmaceutical Services USD 2.6M 700K 2026-06